Skip to content

Aaris Acrylic Intraocular lens(IOL) EC-3 PAL (UDI 00884872025381)Recalls & reported problems

Aaren Scientific Inc. · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00884872025381), received between Oct 3, 2017 and Oct 3, 2017 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Eye Injury1
  • Patient Problem/Medical Problem1
  • Unspecified Infection1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 3, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2017, TWO EC-3 PAL LENSES WERE IMPLANTED INTO THE PATIENT'S EYES. FIFTEEN (15) DAYS POST-OPERATION, THE PATIENT SUFFERED FROM SOME SORT OF FUNGAL GROWTH IN HER LEFT EYE. THE RIGHT EYE HAD NO ISSUES. THE LEFT EYE LENS WAS REMOVED AND FUNGAL GROWTH TREATED WITH ANTIBIOTICS BUT SHOW NO IMPROVEMENT. THE PATIENT'S VISION IS IMPACTED AND REPLACEMENT OF THE LENS SEEMS NOT TO BE AN OPTION. NO ADDITIONAL INFORMATION HAS BEEN PROVIDED.

    Patient problems: Eye Injury; Patient Problem/Medical Problem; Unspecified Infection

    MAUDE report 6909725 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page